Table 1.
Baseline patient characteristics comparing subjects who did and did not actively consume cannabis products
| Demographics | Active cannabis users | Non-users or previous cannabis users | P value |
|---|---|---|---|
| (n = 69) | (n = 1762) | ||
| aAge (years), mean ± SD | 44 ± 19 | 62 ± 19 | < .001 |
| bMale sex, % | 62 | 55 | 0.219 |
| aBMI (kg/m2), mean ± SD | 28.2 ± 7.9 | 28.8 ± 7.4 | 0.554 |
| bRace, column % | |||
| White | 48% | 31% | 0.005 |
| Black | 15% | 9% | 0.136 |
| Asian | 4% | 8% | 0.362 |
| Latinx | 28% | 42% | 0.017 |
| Unknown/mixed race | 6% | 10% | 0.401 |
| bTobacco use, column % | |||
| Never | 55% | 66% | 0.053 |
| Former use | 24.6% | 25.4% | 1.000 |
| Current use | 20% | 4% | < .001 |
| Unknown use | 0c% | 4% | 0.110 |
| bComorbid conditions, column % | |||
| Diabetes mellitus | 23% | 37% | 0.021 |
| Cardiac disease | 16% | 24% | 0.148 |
| Chronic kidney disease | 17% | 27% | 0.094 |
| Chronic pulmonary disease | 26% | 26% | 1.000 |
| Chronic liver disease | 3% | 5% | 0.581 |
Active cannabis use defined as cannabis consumption within 1 month of hospitalization. Any cannabis use thereafter are previous users. Non-users are patients with no history of cannabis use
BMI body mass index
aWelch’s t test
bFisher’s exact test
c % of each level of variable within that particular group, not between groups